• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by bioAffinity Technologies, Inc.

< Previous 1 2 3 4 Next >
News headline image
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
October 20, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
October 16, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
October 15, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
October 09, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
October 08, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
October 07, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Announces Closing of $4.8 Million Public Offering
September 30, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
September 29, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung
September 26, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025
September 17, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules
September 09, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Appoints New Members to Board of Directors
August 18, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
August 14, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Reports Second Quarter 2025 Results
August 14, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
August 13, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales
August 13, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results
July 29, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
Case Study: CyPath® Lung Detects Neuroendocrine Tumor Missed by Other Diagnostic Tools
July 23, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic
July 22, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer Diagnostic
July 15, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
July 09, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference
June 26, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy
June 24, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board
June 11, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung
June 03, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics
May 28, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
May 20, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
bioAffinity Technologies Reports First Quarter 2025 Results
May 15, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
News headline image
Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer
May 08, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF
News headline image
bioAffinity Technologies Announces Closing of $3.25 Million Offering
May 07, 2025
From bioAffinity Technologies, Inc.
Via Business Wire
Tickers BIAF BIAFW
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap